Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Diabetic cardiomyopathy is a common cardiac condition in patients with diabetes mellitus, which results in cardiac hypertrophy and subsequent heart failure. Chronic inflammation in the diabetic heart results in loss of cardiomyocytes and subsequentially cardiac dysfunction. Accumulated evidence implicated pyroptosis as a vital contributor to the hyperglycemia-induced cardiac inflammatory response. Exendin-4, a GLP analog, promotes survival of cardiomyocytes in cardiovascular diseases, including diabetic cardiomyopathy. However, the role of Exendin-4 in cardiac pyroptosis remains to be elucidated. Our study revealed that Exendin-4 treatment protected against heart remolding and dysfunction and attenuated cardiac inflammation in high-fat diet-fed rats. The activity of caspase-1 and production of pyroptotic cytokines were significantly inhibited by Exendin-4 treatment in the diabetic heart and in high glucose-treated cardiomyocytes as well. In an effort to understand the signaling mechanisms underlying the antipyroptotic property of Exendin-4, we found that blockade of AMPK, an oxidative stress sensor, activity diminished the antipyroptotic property of Exendin-4. Phosphorylation of AMPK resulted in degeneration of TXNIP that promoted the activation of the NLRP3 inflammasome. Exendin-4 treatment decreased the protein level of TXNIP. Moreover, RNA silencing of TXNIP mimicked the antipyroptotic actions of Exendin-4. These findings promoted us to propose a new signaling pathway mediating cardioprotective effect of Exendin-4 under hyperglycemic conditions: Exendin-4 → ROS↓ → pAMPK↑ → TXNIP↓ → caspase-1↓ → IL-1 β and IL-18↓ → pyroptosis↓. In general, our study identified Exendin-4 as a pyroptotic inhibitor protecting against hyperglycemia-induced cardiomyocyte pyroptosis via the AMPK-TXNIP pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Beyond improving the metabolic profile, GLP-1 RAs have been shown to significantly reduce serum levels of CRP [80,134,135,136], IL-6 [137] and TNF-α [136].”
From GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives (2023) · cites this paper as [137]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Inflammatory responses and inflammation-associated diseases in organs
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2018) · Oncotarget · doi:10.18632/oncotarget.23208 · Cited by 5,143 · cited 1×
“As shown in previous studies [3, 6, 35, 36], diabetic cardiac tissues express increased level of multiple proinflammatory cytokines promoting progression of myocardial 0.”
BackgroundPyroptosis: host cell death and inflammation
Bergsbaken, T., Fink, S. L., & Cookson, B. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2070 · Cited by 3,183 · cited 1×
“Pyroptosis, the proinflammatory programmed cell death, is mechanistically different from necrosis and apoptosis [10].”
BackgroundIL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
Holman, R. R., Bethel, M. A., Mentz, R. J., Thompson, V. P., Lokhnygina, Y., Buse, J. B., Chan, J. C., Choi, J., Gustavson, S. M., Iqbal, N., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612917 · Cited by 2,162 · cited 1×
“Exendin-4 has been characterized by cardioprotective effects on cardiovascular diseases, including DCM, in human being [31].”
BackgroundFranchi, L., Eigenbrod, T., Muñoz-Planillo, R., & Nuñez, G. (2009) · Nature Immunology · doi:10.1038/ni.1703 · Cited by 1,834 · cited 2×
“The inflammasome is characterized as a molecular dock recruiting procaspase-1 and facilitates its autoactivation [13].”
BackgroundDiabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Jia, G., Hill, M. A., & Sowers, J. R. (2018) · Circulation Research · doi:10.1161/circresaha.117.311586 · Cited by 1,807 · cited 15×
“Pyroptosis is a great contributor to cardiac inflammation in DCM [21].”
BackgroundInfluentialFink, S. L., & Cookson, B. T. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00751.x · Cited by 1,110 · cited 2×
“Pyroptosis results in the release of cytokines that activate proinflammatory immune cells [11, 12].”
BackgroundBan, K., Noyan-Ashraf, M. H., Hoefer, J., Bolz, S.-S., Drucker, D. J., & Husain, M. (2008) · Circulation · doi:10.1161/circulationaha.107.739938 · Cited by 1,057 · cited 13×
“Pyroptosis is a great contributor to cardiac inflammation in DCM [21].”
BackgroundInfluential
Cited by
Entezari, M., Hashemi, D., Taheriazam, A., Zabolian, A., Mohammadi, S., Fakhri, F., Hashemi, M., Hushmandi, K., Ashrafizadeh, M., Zarrabi, A., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112563 · Cited by 400
RetractedGLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
Ma, X., Liu, Z., Ilyas, I., Little, P. J., Kamato, D., Sahebka, A., Chen, Z., Luo, S., Zheng, X., Weng, J., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59965 · Cited by 299
“GLP-1RAs have the potential to inhibit cardiac inflammation via retarding the production of pyroptotic cytokines, caspase-1 and the AMPK-thioredoxin interacting protein (TXNIP) pathway in high-fat diet-fed rats [80].”
BackgroundNevola, R., Epifani, R., Imbriani, S., Tortorella, G., Aprea, C., Galiero, R., Rinaldi, L., Marfella, R., & Sasso, F. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021703 · Cited by 286
“Beyond improving the metabolic profile, GLP-1 RAs have been shown to significantly reduce serum levels of CRP [80,134–136], IL-6 [137] and TNF-α [136].”
BackgroundSong, S., Guo, R., Mehmood, A., Zhang, L., Yin, B., Yuan, C., Zhang, H., Guo, L., & Li, B. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13791 · Cited by 109
Preliminary evidence for the presence of multiple forms of cell death in diabetes cardiomyopathy
Wei, J., Zhao, Y., Liang, H., Du, W., & Wang, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.08.026 · Cited by 112
Liu, B., Wang, Z., He, R., Xiong, R., Li, G., Zhang, L., Fu, T., Li, C., Li, N., & Geng, Q. (2022) · Clinical Science · doi:10.1042/cs20211156 · Cited by 95
Jiang, W., Liu, H., Wan, R., Wu, Y., Shi, Z., & Huang, W. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101315 · Cited by 92
From Innate Immunity to Metabolic Disorder: A Review of the NLRP3 Inflammasome in Diabetes Mellitus
Nițulescu, I. M., Ciulei, G., Cozma, A., Procopciuc, L. M., & Orasan, O. H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12186022 · Cited by 87
“Exenadin-4, a related compound, offers similar benefits [83].”
BackgroundThe Role of the Inflammasome in Heart Failure
Wu, J., Dong, E., Zhang, Y., & Xiao, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.709703 · Cited by 81
Li, S., Qian, Q., Ying, N., Lai, J., Feng, L., Zheng, S., Jiang, F., Song, Q., Chai, H., & Dou, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.560905 · Cited by 78
Pyroptosis in the Retinal Neurovascular Unit: New Insights Into Diabetic Retinopathy
Meng, C., Gu, C., He, S., Su, T., Lhamo, T., Draga, D., & Qiu, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.763092 · Cited by 78
“Hyperglycemia induced cardiomyocyte pyroptosis in high-fat diet-induced T2DM mice via the AMPK-TXNIP pathway (117).”
BackgroundProgrammed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches
Cai, K., Jiang, H., Zou, Y., Song, C., Cao, K., Chen, S., Wu, Y., Zhang, Z., Geng, D., Zhang, N., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107281 · Cited by 80
Le, R., Nguyen, M. T., Allahwala, M. A., Psaltis, J. P., Marathe, C. S., Marathe, J. A., & Psaltis, P. J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164674 · Cited by 66
“GLP-1 RAs can additionally guard against hyperglycaemia-induced autoinflam-matory damage, inhibiting NLR family pyrin domain-containing 3 (NLRP3) inflammasome formation and thereby conferring anti-pyroptotic effects on cardiomyocytes [133].”
BackgroundDomingues, A., Jolibois, J., Marquet, P., & Nivet‐Antoine, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041693 · Cited by 69
“This inflammation state can trigger cell senescence or cell death characterized as pyroptosis, which is hampered with the decrease of TXNIP [66,78,92,93,105].”
BackgroundOxidative Stress Signaling Mediated Pathogenesis of Diabetic Cardiomyopathy
Tang, Z., Wang, P., Dong, C., Zhang, J., Wang, X., & Pei, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5913374 · Cited by 77
“On the other hand, exendin-4, as an anti-oxidant, can not only directly inhibit the activation of caspase-1 but also indirectly suppress the activation of caspase-1 by downregulating TXNIP to prevent myocardial pyroptosis caused by high glucose [55].”
Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response
Kaur, N., Guan, Y., Raja, R., Ruiz‐Velasco, A., & Liu, W. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.694864 · Cited by 70
Pandey, S., Mangmool, S., & Parichatikanond, W. (2023) · Pharmaceuticals · doi:10.3390/ph16060836 · Cited by 56
Pyroptosis: Mechanisms and links with diabetic cardiomyopathy
Liu, P., Zhang, Z., Chen, H., & Chen, Q. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102182 · Cited by 65
Pyroptosis-Related Inflammasome Pathway: A New Therapeutic Target for Diabetic Cardiomyopathy
Cai, Z., Yuan, S., Luan, X., Feng, J., Deng, L., Zuo, Y., & Li, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.842313 · Cited by 56
“In summary, the ROS-AMPK-TXNIP pathway can serve as a link between oxidative stress and cardiac inflammation in various CVDs (Wei et al., 2019).”
BackgroundInfluentialRedox-dependent and independent effects of thioredoxin interacting protein
Cao, X., He, W., Pang, Y., Cao, Y., & Qin, A. (2020) · Biological Chemistry · doi:10.1515/hsz-2020-0181 · Cited by 54
Xia, W., Hu, S., Wang, M., Xu, F., Han, L., & Peng, D. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113641 · Cited by 50
The crosstalk among autophagy, apoptosis, and pyroptosis in cardiovascular disease
Cong, L., Bai, Y., & Guo, Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.997469 · Cited by 50
“Phosphorylation of AMPK leads to the degeneration of TXNIP, thereby promoting the activation of the NLRP3 inflammasome (97).”
BackgroundPCSK9: A emerging participant in heart failure
Xu, Q., Zhao, Y.-M., He, N.-Q., Gao, R., Xu, W., Zhuo, X.-J., Ren, Z., Wu, C., & Liu, L. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114106 · Cited by 50
Chen, C., Wang, J., Zhang, S., Zhu, X., Hu, J., Liu, C., & Liu, L. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103321 · Cited by 56
Zhang, X., Qu, H., Yang, T., Kong, X., & Zhou, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112219 · Cited by 51
The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications
Ding, K., Song, C., Hu, H.-J., Yin, K., Huang, H., & Tang, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3790721 · Cited by 49
“It has been reported that exendin-4, a GLP-1 analog, reduces ROS formation through the AMPK-TXNIP pathway in type 2 diabetic mice induced by a high-fat diet to attenuate NLRP3 in fl ammasome activity, thereby improving cardiac dysfunction and remodeling [145].”
Das, S., Mukherjee, U., Biswas, S., Banerjee, S., Karmakar, S., & Maitra, S. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.124922 · Cited by 47
Balogh, D. B., Wagner, L. J., & Fekete, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097789 · Cited by 38
“In a high-fat diet T2DM mice model, exendin4 protected against heart remodeling and attenuated the levels of IL-1β, IL-6, TNF-α, ICAM-1, and VCAM-1 by inhibiting NLRP3 inflammasome-dependent inflammatory pathways [66,67].”
BackgroundTargeting the AMPK/Nrf2 Pathway: A Novel Therapeutic Approach for Acute Lung Injury
Huang, Q., Ren, Y., Yuan, P., Huang, M., Liu, G., Shi, Y., Jia, G., & Chen, M. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s467882 · Cited by 46
“Additionally, it suppresses the expression of NLRP3 by inhibiting the phosphorylation of the NF-κB p65 subunit, 123,124 thereby alleviating ALI.”
BackgroundHavranek, B., Loh, R., Torre, B., Redfield, R. L., & Halegoua-DeMarzio, D. L. (2025) · Scientific Reports · doi:10.1038/s41598-025-89408-z · Cited by 51
Liu, F., Wang, X., Cui, Y., Yin, Y., Qiu, D., Li, S., & Li, X. (2021) · Foods · doi:10.3390/foods10112711 · Cited by 41
“Subsequently, Cleaved-Caspase-1 triggers the maturation of interleukin-1β (IL-1β) and interleukin-18 (IL-18) and processes gasdermin D (GSDMD) into GSDMD-N, ultimately resulting in pyroptosis [18].”
BackgroundShen, Q., Chen, Y., Shi, J., Pei, C., Chen, S., Huang, S. M., Li, W., Shi, X., Liang, J., & Hou, S. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175504 · Cited by 37
Self-citationLi, X., Xiao, G.-Y., Guo, T., Song, Y., & Li, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.986565 · Cited by 45
Quan, X., Ye, J., Yang, X., & Xie, Y. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112802 · Cited by 38
Li, K., Wang, Y., Chen, C., Wang, X., & Li, W. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156430 · Cited by 42
GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies
Yang, H. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14196758 · Cited by 46
“Semaglutide treatment in diabetic rats increased myocardial SOD activity by 35% and reduced malondialdehyde levels, a marker of lipid peroxidation, by 45% [77].”
Tang, T.-J., Wang, X., Wang, L., Chen, M., Cheng, J., Zuo, M., Gu, J., Ding, R., Zhou, P., & Huang, J. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14351 · Cited by 34
Wu, Q., Li, D., Huang, C., Zhang, G., Wang, Z., Liu, J., Yu, H., Song, B., Zhang, N., Li, B., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113517 · Cited by 34
Exenatide improves random‐pattern skin flap survival via TFE3 mediated autophagy augment
Li, J., Chen, H. A., Lou, J., Bao, G., Wu, C., Lou, Z., Wang, X., Ding, J. H., Li, Z., Xiao, J., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30102 · Cited by 35
“More recently, exenatide has also been shown to inhibit pyroptosis and prevent hyperglycemia‐induced cardiomyocyte pyroptosis through the activation of the AMPK pathway (Wei et al., 2019).”
BackgroundZhang, Y., Song, Y., Wang, C., Jiang, J., Liu, S., Bai, Q., Li, L., Jin, H., Jin, Y., & Yan, G. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115106 · Cited by 38
Liu, Y., Shu, J., Liu, T., Xie, J., Li, T., Li, H., & Li, L. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175365 · Cited by 30
Self-citationLiu, Z., Chen, Y., Yu, M., Yan, M., & Liang, H. (2023) · Molecules · doi:10.3390/molecules28237813 · Cited by 28
“For instance, Exendin-4 has been reported to reduce NLRP3/caspase-1-dependent pyroptosis in diabetic cardiomyocytes by regulating the ROS–AMPK–TXNIP signaling pathway [81], where AMPK activation is driven by oxidative stress through ROS-dependent phosphorylation.”
BackgroundSelf-citationSun, Z., Chai, Q., Zhang, Z., Lu, D., Meng, Z., & Wu, W. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119116 · Cited by 25
Zhang, Z., Wang, X., Yang, L., Yang, L., & Ma, H. (2021) · PubMed Central · doi:10.22038/ijbms.2021.56771.12677 · Cited by 30
“a GLP analog, protected against hyperglycemia-induced cardiomyocyte pyroptosis via the AMPK/thioredoxininteracting protein (TXNIP) pathway (36).”
BackgroundZhang, Q. H., Wang, S., & Ji, S. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13654 · Cited by 22
“AMPK activation suppressed TXNIP that is a component of NLRP3 inflammasome.(36,37) Moreover, NLRP3 inflammasome activation was reduced in DSS-induced UC mice via inactivating AMPK-TXNIP pathway.”
BackgroundCao, Q., Zhang, Z., Zhao, J., Feng, L., Jiang, W., Wu, P., Zhao, J., Liu, H., & Jun, J. (2024) · Animal nutrition · doi:10.1016/j.aninu.2024.09.002 · Cited by 20
Novel Insights Into the Pathogenesis of Diabetic Cardiomyopathy and Pharmacological Strategies
Muñoz‐Córdova, F., Hernández-Fuentes, C. P., López‐Crisosto, C., Troncoso, M. F., Calle, X., Guerrero‐Moncayo, A., Gabrielli, L., Chiong, M., Castro, P., & Lavandero, S. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.707336 · Cited by 21
“Exendin4, an analog of the incretin GLP-1 used to treat diabetes, prevents the systolic dysfunction in HFD-fed mice, also reduces the markers of pyroptosis, such as caspase-1 activation and IL-1β and IL-18 release, in mice cardiomyocytes exposed to high glucose (33).”
BackgroundZhou, K. Q., Dhillon, S. K., Bennet, L., Gunn, A. J., & Davidson, J. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710191 · Cited by 20
Lymperopoulos, A., Borges, J. I., & Stoicovy, R. A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060693 · Cited by 23
Wang, M., Yang, Q., Li, Y., Zhao, Y., Zou, J., Luan, F., Peng, X., Huang, Z., & Liu, F. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01222-x · Cited by 19
“The activation of thioredoxin-interacting protein in β-cells further promotes cell lysis and death, intensifying the inflammatory cascade [75].”
Self-citationLiu, H.-Y., Chang, C., Lu, C., Wu, S., Huang, B., Cheng, T., Lin, S., Ho, C.-J., Lee, M., Yang, C., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10071477 · Cited by 18
Chai, Q., Meng, Z., Lu, D., Zhang, Z., Liu, M., & Wu, W. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04104-6 · Cited by 14
Galectin-3 induces vascular smooth muscle cells calcification via AMPK/TXNIP pathway
Tian, L., Wang, Y., & Zhang, R. (2022) · Aging · doi:10.18632/aging.204130 · Cited by 13
“However, in galectin-3 treatment VSMCs, TXNIP expression is significantly upregulated, it seems that AMPK activation is not sufficient for TXNIP degeneration, TXNIP desensitization may attenuate efficiency of P-AMPK upregulation on TXNIP degeneration [35], besides the AMPK activation and TXNIP degeneration are also ob…”
BackgroundReactive oxygen species in cardiovascular diseases: an update
Fei, J., Demillard, L. J., & Ren, J. T. (2022) · Exploration of Medicine · doi:10.37349/emed.2022.00085 · Cited by 17
“Lastly, iNOS is up-regulated in DCM, with increased levels of 4-hydroxynonenal (4-HNE) [59].”
BackgroundInfluentialTargeting Pyroptosis: New Insights into the Treatment of Diabetic Microvascular Complications
Gu, J., Geng, K., Guo, M., Huang, W. G., Zhao, T., Li, X., Xu, Y., & Xu, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/5277673 · Cited by 14
“, metformin [91], exendin-4 [92], pyrroloquinoline quinone (PQQ) [93], and skimming) [94].”
Sawamura, T., Mizoguchi, R., Ohmori, A., Kometani, M., Yoneda, T., & Karashima, S. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01472-w · Cited by 18
Pleiotropy of PCSK9: Functions in Extrahepatic Tissues
Şener, Y. Z., & Tokgözoğlu, L. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01918-2 · Cited by 13
Ismaeil, A., Babiker, F. A., & Al‐Sabah, S. (2022) · Pharmaceuticals · doi:10.3390/ph15060720 · Cited by 15
“Reductions in ROS by Ex-4 and GLP-1 (9-36) in the protection of cardiomyocytes were also reported previously [53,54].”
ResultWang, T., Yang, Q., Cheng, X.-Y., Ding, J.-C., & Hu, P.-F. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10438-2 · Cited by 14
Self-citationKarakasis, P., Patoulias, D., Giannakoulas, G. A., Sagris, Μ., Theofilis, P., Fragakis, N., & Biondi‐Zoccai, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216411 · Cited by 13
“These mechanisms collectively exert anti-inflammatory effects, including reduced leukocyte adhesion [50].”
BackgroundThe Role of AMPKα in the Mechanism of Development and Treatment of Heart Failure
Feng, Y., Zhu, Z., He, Y., & Li, X. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm36391 · Cited by 11
The Role of Pyroptosis in Coronary Heart Disease
Qiu, Y., Meng, L., Xing, Y., Peng, J., Zhou, Y., Yu, Z., Liu, H., & Peng, F. (2024) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2024.4001 · Cited by 12
“52,53 When CMs undergo molecular biological changes in association with neural and humoral factors, they can also lead to structural and functional disturbances of the heart, compensatory VR disorders, and eventually HF. Tissue protease B (CTSB) is a hydrolase located in the lysosomes of CMs.…”
BackgroundKhine, H. E. E., Mangmool, S., & Parichatikanond, W. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178233 · Cited by 9
Potential diabetic cardiomyopathy therapies targeting pyroptosis: A mini review
Yu, J., Li, D., Yu, J. Y., Jiang, W., Liao, X., & Zhao, Q. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.985020 · Cited by 12
“Additionally, exendin-4 inhibits pyroptosis via the ROS/AMPK/TXNIP/NLPR3 pathway, indicating that exendin4 is a potential therapeutic drug for DCM (47).”
BackgroundGlucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Pan-Steatotic Liver Disease Treatment?
Chrysavgis, L., Mourelatou, N. G., & Cholongitas, Ε. (2025) · Biomedicines · doi:10.3390/biomedicines13071516 · Cited by 10
“On a molecular level, GLP-1 signaling has been shown to suppress pro-inflammatory cytokine production, such as that of tumor necrosis factor-α and interleukin-6, and reduce oxidative stress, both of which contribute to hepatocellular injury and disease progression in MASLD and MetALD/ALD [70].”
Geng, X., Shang, W.-Y., Qi, Z., Zhang, C., Li, W.-X., Yan, Z., Fan, X., & Zhang, J. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108848 · Cited by 9
Li, N., Wen, X., Tang, M., Peng, X.-M., Sheng, Q., & Liu, P. (2022) · Quality Assurance and Safety of Crops & Foods · doi:10.15586/qas.v14i2.990 · Cited by 8
“AMPK promoted the activation of NLRP3 inflammasome to suppress hyperglycemia-induced pyroptosis in cardiomyocytes through degeneration of TXNIP (Wei et al., 2019).”
BackgroundNLR/inflammasome pathway in cardiovascular disorders: from pathogenesis to potential therapies
Hammami, B., Zare, N., Sohrabi, A., Alimohammady, M., Eghlidi, M. S., & Naderi, N. (2025) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2025.2515322 · Cited by 7
“The ROS-AMPK-TXNIP pathway mediated the anti-pyroptotic effect of exendin-4 [90].”
Tudurachi, B.-S., Anghel, L., Tudurachi, A., Sascău, R. A., Zanfirescu, R.-L., & Stătescu, C. (2024) · Biomedicines · doi:10.3390/biomedicines12061314 · Cited by 7
“Enhance mitochondrial activities by targeting inflammatory and autophagy processes and suppressing cardiomyocyte pyroptosis via the AMPK-TXNIP pathway [180,181].”
Wang, T., Duan, R., Li, Z., Zhang, B., Jiang, Q., Jiang, L., Lv, J., Su, W., & Feng, L. (2025) · JCI Insight · doi:10.1172/jci.insight.184072 · Cited by 7
Bibliometric and visual analysis of diabetes mellitus and pyroptosis from 2011 to 2022
Li, X., Su, X., Xia, F., Qiu, J., Zhang, J., Wu, H., Xie, X., & Xu, M. (2023) · European journal of medical research · doi:10.1186/s40001-023-01175-7 · Cited by 7
“More progress has been made in the study of signaling pathways related to DCM pyroptosis, including TLR4/NF-kB/NLRP3 inflammatory vesicle signaling pathway [37, 38], AMPK/ROS/TXNIP/NLRP3 inflammatory vesicle signaling pathway [39], AMPK/SIRT1/Nrf2/ HO-1/NF-kB inflammatory vesicle signaling pathway [40, 41] and the Fox…”
BackgroundHe, L., Lu, F., Zhang, F., Fan, S., & Xu, J. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113806 · Cited by 6
Zhang, Z., Lu, P., Dang, S., Wang, N., Zhao, S.-Y., Li, F., Wu, L., Zhang, L., Liu, H., Zhao, N., et al. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04134-0 · Cited by 5
“The increase level of Txnip and excessive oxidative stress contribute to myocardium apoptosis in diabetes [12].”
BackgroundSun, M. J., Liu, G., Wang, M., Wang, W., Zhang, Z., Yu, H. M., Sun, H., Wang, C., & Liu, W. (2025) · Phytotherapy Research · doi:10.1002/ptr.70047 · Cited by 5
“HG stimulated the phosphorylation of AMP-activated protein kinase (AMPK) to induce TXNIP degeneration, which promoted the activation of NLRP3 inflammasome-induced pyroptosis in cardiomyocytes (Wei et al. 2019).”
Rimal, N., Khanal, S., Bohara, G., & Choi, D. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110643 · Cited by 7
Li, G., He, S., Liu, T., & Zheng, N. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12565 · Cited by 6
“HG induces production of ROS, which in turn activates oxida‑ tive stress responses (17,32,33).”
BackgroundResultGupta, P., & Ekbbal, R. (2023) · Current Drug Research Reviews · doi:10.2174/0125899775243787231103075804 · Cited by 5
Date, S., & Bhatt, L. K. (2025) · Archiv der Pharmazie · doi:10.1002/ardp.70082 · Cited by 7
“This cascade of events reduces inflammation, alleviates oxidative stress, and prevents myocardial damage, thereby protecting cardiomyocytes and improving cardiac function in a diabetic environment [22].”
InfluentialLyu, J., Imachi, H., Fukunaga, K., Sato, S., Kobayashi, T., Saheki, T., Japar, S., Iwama, H., Matsumura, Y., Ozaki, M., et al. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44110370 · Cited by 4
“Previous studies demonstrated that the activation of the AMPK pathway by exendin-4 was also involved in the process of attenuating cardiac hypertrophy [30], protecting against hyperglycemia-induced cardiomyocyte pyrotosis [31] and protecting endothelial cells from lipoapoptosis [32], which may also contribute to the e…”
BackgroundNon-coding RNAs modulate pyroptosis in diabetic cardiomyopathy: A comprehensive review
Shang, W., Geng, X., Sun, X., Fan, X., Li, A., Zhang, C., Kang, Y., Liang, Y., & Zhang, J. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142865 · Cited by 5
Cai, L., Tan, Y., Islam, M. S., Horowitz, M., & Wintergerst, K. A. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i8.1659 · Cited by 3
Roles of transient receptor potential channel 6 in glucose-induced cardiomyocyte injury
Jiang, S. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i4.338 · Cited by 2
GLP-1 receptor agonism in cardiovascular disease prevention
Saleh, H. (2025) · Asia-Pacific Journal of Pharmacotherapy & Toxicology · doi:10.32948/ajpt.2024.11.22 · Cited by 1
Trend Research of Diabetes and Pyroptosis: Bibliometric Analysis and Literature ReviewPreprint
Li, X., Xiaojuan, S., & Mingchao, X. (2023) · Preprints.org · doi:10.20944/preprints202301.0096.v1 · Cited by 1
He, S., Zhang, J., Wang, T., Wu, P., Liu, J., Li, M., & Ma, B. (2020) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-020-10123-6
Effect of Incretogenic Peptides on Non-Alcoholic Fatty Liver Disease
苏, 怡. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1361396
Effect of Submaximal-Dose Semaglutide on MASLD Biopsy-Free Scoring Systems in Patients with Obesity
Focko, B., Péč, M. J., Miertová, Z., Jurica, J., Miert, A., Kubikova, L., Tudík, P., Nagy, N., Lecký, P., Ságová, I., et al. (2026) · Livers · doi:10.3390/livers6010003
“…effects on hepatocytes, GLP-1RA have also been demonstrated to dramatically lower serum C-reactive protein, tumour necrosis factor-α and interleukin-6, all of which are linked to liver inflammation, the onset of hepatocellular carcinoma, and the advancement of non-alcoholic steatohepatitis [26–32].”
Li, X., Zhou, T., Wu, Y., Sun, J., Wang, Z., Huang, Y., Xu, K., Ling, H., Li, N., Yang, T., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116416
Almohya, S. M., & Alqahtani, N. S. (2026) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203261431906
Liu, F., Xu, Z., Wang, W., Gao, J., Changgeng, F. U., & Liu, P. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1996288
Metadata
- Authors
- Wei, H., Bu, R., Yang, Q., Jia, J., Li, T., Wang, Q., & Chen, Y.
- Affiliations
- Harbin Medical University (CN)
- Peking University Shenzhen Hospital (CN)
- Corresponding author
- Chen, Yanjun
- Venue
- Journal of Diabetes Research
- Publisher
- Wiley
- Published
- 2019-12-09
- Volume
- 2019
- Pages
- 1-13
- ISSN
- 2314-6745 (ISSN-L)
- 2314-6753
- PMC
- PMC6925927
- OpenAlex
- W2993303703
- Cited by
- 91
- References
- 44
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 17 · 2023: 12 · 2022: 24 · 2021: 15 · 2020: 5
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Diabetes Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Project of Health Commission of Heilongjiang Province (2018068)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- exendin-4, cardiomyocyte pyroptosis, diabetic cardiomyopathy, hyperglycemia, AMPK, TXNIP, NLRP3 inflammasome, caspase-1, IL-1β, IL-18, oxidative stress, GLP-1 receptor agonists, cardiac inflammation, heart failure
- MeSH terms
- Pyroptosis, NLR Family, Pyrin Domain-Containing 3 Protein, Exenatide, Animals, Blood Glucose, Carrier Proteins, Cells, Cultured, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Hypoglycemic Agents, Mice, Inbred C57BL, Phosphorylation, Thioredoxins, Signal Transduction, Biomarkers, Reactive Oxygen Species, Caspase 1, Interleukin-18, Myocytes, Cardiac, Interleukin-1beta, Incretins, AMP-Activated Protein Kinases, Diabetic Cardiomyopathies, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.